Editorial Urges Action To Boost Access to Generic Drugs
Members of Congress should use health care reform legislation to close a loophole in current law that lets drugmakers pay rivals to delay the introduction of lower-cost generic medications into the market, an editorial states, going on to endorse language from the House bill that "simply bans the practice."
- "Health Care Reform Should Put an End to Pay-for-Delay by Drug Companies" (Washington Post, 1/15).